KBC Group NV - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 41 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
KBC Group NV ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2021$204,000
-6.4%
200,0000.0%0.00%
Q4 2020$218,000
+5.8%
200,0000.0%0.00%
Q3 2020$206,000
-68.9%
200,000
-66.7%
0.00%
-100.0%
Q2 2020$662,000
+117.0%
600,000
+100.0%
0.00%
-33.3%
Q1 2020$305,000
-11.3%
300,0000.0%0.00%
+50.0%
Q4 2019$344,000300,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q4 2020
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 73,641,000$58,038,0004.94%
STEELHEAD PARTNERS LLC 52,496,000$62,306,0004.87%
SILVERBACK ASSET MANAGEMENT LLC 25,000,000$29,656,0004.56%
Castle Creek Arbitrage, LLC 10,734,000$12,733,0003.32%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,132,000$47,726,0002.41%
Sonora Investment Management, LLC 17,232,000$20,380,0002.28%
TORONTO DOMINION BANK 1,000,002$5,947,335,0001.84%
TFG Asset Management GP Ltd 8,500,000$10,084,0001.46%
SYMPHONY ASSET MANAGEMENT LLC 5,000,000$5,925,0001.24%
SSI INVESTMENT MANAGEMENT LLC 13,441,000$15,893,0001.18%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders